BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
2. 95
+0.05
+1.5491%
$
236.51M Market Cap
- P/E Ratio
- Div Yield
473,900 Volume
- Eps
$ 2.9
Previous Close Investors:
Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Oncology Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Anthony Scaramucci SkyBridge Capital II LLC | 1.76M | $18.39M | $5.12M | -$13.27M | -72.14% |
 Taro Kuriyama Axq Capita LLP | 10,728 | $96,015.82 | $31,379.4 | -$64,636.42 | -67.32% |
 Olga Maltseva Catalio Capital Management LP | 318,407 | $2.43M | $952,036.93 | -$1.47M | -60.76% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 37 | $287.51 | $109.15 | -$178.36 | -62.04% |
| WJ William Jones TEMA ETFs LLC | 93,339 | $820,531.52 | $271,149.79 | -$549,381.73 | -66.95% |
2026 © Marketlog. All Rights Reserved.
